Open AccessPrognostic significance of BMP and activin membranebound inhibitor in colorectal cancer
Author(s) -
Nozomi Togo,
Susumu Ohwada,
Shunsuke Sakurai,
Hiroyuki Toya,
Ichiro Sakamoto,
Tatsuya Yamada,
Tetsuhiro Nakano,
Ken Muroya,
Izumi Takeyoshi,
Takashi Nakajima,
Takashi Sekiya,
Yusuke Yamazumi,
Tsutomu Nakamura,
Tetsu Akiyama
Publication year - 2008
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.14.4880
Subject(s) - immunohistochemistry , colorectal cancer , medicine , cancer research , oncology , cancer
To investigate the clinical significance of BMP and activin membrane-bound inhibitor (BAMBI) which is a pseudoreceptor of transforming growth factor-beta (TGF-beta) type I receptors and acts as a negative regulator of TGF-beta signaling and expression aberrantly elevated in colorectal cancers (CRCs). We studied BAMBI expression in CRCs.